Drug recall

Legal action against a prescription drug

A drug recall removes a prescription or over the counter drug from the market. Drug recalls in the United States are made by the FDA or the creators of the drug when certain criteria are met. When a drug recall is made, the drug is removed from the market and potential legal action can be taken depending on the severity of the drug recall. Drug recalls are classified in the US by the FDA in three different categories. Class I recalls are the most severe and indicate that exposure and/or consumption of the drug will lead to adverse health effects or death. Class II recalls refer to drugs that induce temporary and/or medically reversible health effects. Class III recalls occur when adverse health effects are not likely to occur when consuming the drug or being exposed to it. and medical device safety alerts'.

In 1971, Diethylstilbestrol (DES) was recalled from the market. It was intended to be used to prevent prenatal problems during pregnancy. Women who took DES were shown to have a greater chance of having breast cancer. It is estimated that 5 to 10 million persons were exposed to DES until its recall in 1971. Both mothers and second generation daughters are confirmed to have adverse side effects from DES. Daughters of DES Mothers are more than twice as likely to form breast cancer and are 2.4 times as likely to be infertile. Sons of DES mothers have displayed side effects like genital abnormalities, non cancerous Epididymal Cysts, and infertility.

The FDA will issue different levels of recall depending on the severity of the effects. From most to least severe, there is Class I, Class II, and Class III (defined above). There is also market withdrawal which occurs when a drug does not violate FDA regulation but has a known, minor default. The producer must either fix the default or take the drug off the market. Drugs and medical devices are typically recalled if the product is defective, contaminated, contains a foreign object, fails to meet specifications, mislabeled, or misbranded. Misbranding was the most common reason for pharmaceutical recalls in 2015, accounting for 42%.

The recall process in the United States follows three approximate phases. Distinct difficulties arise depending on the type of drug being recalled. Drug recalls can be initiated by the producing firm or the FDA, and those launched by the FDA can be either mandatory or voluntary. This is applicable not just to drugs but all products covered under the FDA.

The 21st Century Cures Act would allow for faster approval of certain drugs, which could result in additional recalls. It passed both houses of Congress and was signed into law by US President Barack Obama on December 13, 2016. In 2015, 45 new drugs were passed by the FDA, which is more than double than the approval rate 10 years ago. The 21st Century Cures Act could make this number a trend rather than aberration by expediting approval through lower standards, much like the FDA Modernization Act of 1997.